PASITHEA THERAPEUTICS CORP (KTTA) Forecast, Price Target & Analyst Ratings

NASDAQ:KTTA • US70261F2020

Current stock price

0.7424 USD
+0.01 (+0.87%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PASITHEA THERAPEUTICS CORP (KTTA).

Forecast Snapshot

Consensus Price Target

Price Target
$3.06
+ 312.18% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.46
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.06
Upside
+ 312.18%
From current price of $0.74 to mean target of $3.06, Based on 7 analyst forecasts
Low
$3.03
Median
$3.06
High
$3.15

Price Target Revisions

1 Month
50.00%
3 Months
50.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for KTTA. The average price target is 3.06 USD. This implies a price increase of 312.18% is expected in the next year compared to the current price of 0.7424.
The average price target has been revised upward by 50% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KTTA Current Analyst RatingKTTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

KTTA Historical Analyst RatingsKTTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
KTTA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KTTA.
In the previous month the buy percentage consensus was at a similar level.
KTTA was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-08HC Wainwright & Co.Initiate Buy
2023-07-10EF HuttonReiterate Buy -> Buy
2023-04-03EF HuttonMaintains Buy
2021-12-14EF HuttonInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.46
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

KTTA is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.46 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
KTTA revenue by date.KTTA revenue by date.
15.1K510K
-100.00%		N/A
EBITDA
YoY % growth
KTTA ebitda by date.KTTA ebitda by date.
N/A-4.506M-12.138M
-179.27%		-9.486M
-21.83%		N/A-15.096M-55.08M
-264.86%		-65.994M
-19.81%		-80.274M
-21.64%
EBIT
YoY % growth
KTTA ebit by date.KTTA ebit by date.
-41K-4.507M
-10,893.66%		N/A
-179.30%		N/A
-26.93%		N/A-15.096M-17.544M
-16.22%		-21.726M
-23.84%		-27.642M
-27.23%
Operating Margin
KTTA operating margin by date.KTTA operating margin by date.
N/A-29,850.33%N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
KTTA eps by date.KTTA eps by date.
N/AN/A-0.56
92.14%		-0.72
-29.09%		N/A-1.53-1.90
-24.00%		-2.14
-12.90%		-2.35
-9.52%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.46-0.46-0.49-0.49
38.03%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-11.526M
-227.58%		-12.546M
-259.75%		-14.688M
-463.82%		-16.32M
-200.52%
EBIT
Q2Q % growth		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KTTA Yearly Revenue VS EstimatesKTTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 100K 200K 300K 400K 500K
KTTA Yearly EPS VS EstimatesKTTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2025 2026 2027 2028 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PASITHEA THERAPEUTICS CORP / KTTA Forecast FAQ

Can you provide the average price target for PASITHEA THERAPEUTICS CORP stock?

7 analysts have analysed KTTA and the average price target is 3.06 USD. This implies a price increase of 312.18% is expected in the next year compared to the current price of 0.7424.

When does PASITHEA THERAPEUTICS CORP (KTTA) report earnings?

PASITHEA THERAPEUTICS CORP (KTTA) will report earnings on 2026-05-13.

What are the consensus estimates for PASITHEA THERAPEUTICS CORP (KTTA) next earnings?

The consensus EPS estimate for the next earnings of PASITHEA THERAPEUTICS CORP (KTTA) is -0.46 USD and the consensus revenue estimate is 0 USD.